Acanthosis nigricans in a child with mild osteochondrodysplasia and K650Q mutation in the FGFR3 gene
暂无分享,去创建一个
Jo Lambert | Lieve Nuytinck | G. Mortier | J. Lambert | J. Naeyaert | L. Nuytinck | J. Leroy | Jules G Leroy | Jean-Marie Naeyaert | Geert R Mortier
[1] J. Bonaventure,et al. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia , 2006, European Journal of Human Genetics.
[2] Jean Weissenbach,et al. A gene for achondroplasia–hypochondroplasia maps to chromosome 4p , 1994, Nature Genetics.
[3] J. Gusella,et al. The gene for achondroplasia maps to the telomeric region of chromosome 4p , 1994, Nature Genetics.
[4] S. Rosengren,et al. Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. , 2000, American journal of human genetics.
[5] A. Superti-Furga,et al. Nosology and classification of genetic skeletal disorders: 2006 revision , 2007, American journal of medical genetics. Part A.
[6] G. Bellus,et al. Genes, growth factors and acanthosis nigricans , 2002, The British journal of dermatology.
[7] G. Mortier,et al. Clinical and radiographic features of a family with hypochondroplasia owing to a novel Asn540Ser mutation in the fibroblast growth factor receptor 3 gene , 2000, Journal of medical genetics.
[8] I. Munro,et al. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans , 1995, Nature Genetics.
[9] E. Haan,et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. , 1997, American journal of human genetics.
[10] D. Rimoin,et al. Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia. , 1998, American journal of medical genetics.
[11] S. Robertson,et al. Somatic and germline mosaicism for a R248C missense mutation in FGFR3, resulting in a skeletal dysplasia distinct from thanatophoric dysplasia , 2003, American journal of medical genetics. Part A.
[12] M. Bamshad,et al. Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3. , 1999, American journal of medical genetics.
[13] I. Kaitila,et al. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia , 1995, Nature Genetics.
[14] D. Donoghue,et al. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. , 1999, American journal of human genetics.
[15] D. Church,et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia , 1994, Cell.
[16] R. Pauli,et al. Long-term survival in typical thanatophoric dysplasia type 1. , 1997, American journal of medical genetics.
[17] D. Rimoin,et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3 , 1995, Nature Genetics.
[18] M. Muenke,et al. Prevalence of Pro250Arg mutation of fibroblast growth factor receptor 3 in coronal craniosynostosis , 1997, The Lancet.
[19] D. Meyers,et al. Localization of the achondroplasia gene to the distal 2.5 Mb of human chromosome 4p. , 1994, Human molecular genetics.
[20] S. Blanton,et al. Confirmatory linkage of hypochondroplasia to chromosome arm 4p. , 1995, American journal of medical genetics.
[21] P. Prinos,et al. A common FGFR3 gene mutation in hypochondroplasia. , 1995, Human molecular genetics.
[22] M. Cohen Jr.,et al. The new bone biology: pathologic, molecular, and clinical correlates. , 2006, American journal of medical genetics. Part A.